{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:13:44Z","timestamp":1791764024757,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.survophthal.2021.05.005","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T11:23:09Z","timestamp":1620991389000},"page":"83-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Pentosan polysulfate maculopathy"],"prefix":"10.1016","volume":"67","author":[{"given":"Aaron","family":"Lindeke-Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2218-6611","authenticated-orcid":false,"given":"Nieraj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.survophthal.2021.05.005_bib0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3928\/23258160-20201223-04","article-title":"New insights into pentosan polysulfate maculopathy","volume":"52","author":"Abou-Jaoude","year":"2021","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.005_bib0002","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ophtha.2016.12.034","article-title":"Histologic and optical coherence tomographic correlates in drusenoid pigment epithelium detachment in age-related macular degeneration","volume":"124","author":"Balaratnasingam","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.oret.2020.05.008","article-title":"Pentosan polysulfate maculopathy versus inherited macular dystrophies: comparative assessment with multimodal imaging","author":"Barnes","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0004","article-title":"Potential new onset clinically detectable pentosan polysulfate maculopathy years after drug cessation","author":"Barnett","year":"2021","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0005","article-title":"Pentosan polysulfate maculopathy versus age-related macular degeneration: comparative assessment with multimodal imaging","author":"Christiansen","year":"2021","journal-title":"Can J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.005_bib0006","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1167\/iovs.05-0805","article-title":"ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina","volume":"46","author":"Cideciyan","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.survophthal.2021.05.005_bib0007","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1167\/iovs.11-7909","article-title":"Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera","volume":"52","author":"Clark","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0008","article-title":"Pentosan polysulfate sodium-induced pigmentary maculopathy with non-leaking cystoid macular edema successfully treated with anti-VEGF therapy","author":"De Larochelli\u00e8re","year":"2020","journal-title":"Retin Cases Brief Rep"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.005_bib0009","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1167\/iovs.14-16343","article-title":"Quantitative fundus autofluorescence and optical coherence tomography in PRPH2\/RDS- and ABCA4-associated disease exhibiting phenotypic overlap","volume":"56","author":"Duncker","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0010","unstructured":"Janssen PharmaceuticalsElmiron (R) [package insert].Janssen Pharmaceuticals, Titusville, NJ, August 2012."},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.005_bib0011","first-page":"159","article-title":"Thrombocid: a new synthetic anticoagulant","volume":"59","author":"Frileux","year":"1951","journal-title":"Presse Med"},{"issue":"9","key":"10.1016\/j.survophthal.2021.05.005_bib0012","first-page":"2352","article-title":"Systemic pentosan polysulfate administration causes retinal function loss in the C57Bl\/6J mouse","volume":"60","author":"Girardot","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.005_bib0013","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/14656566.2018.1491968","article-title":"An evaluation of the pharmacotherapy for interstitial cystitis","volume":"19","author":"Giusto","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.005_bib0014","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2018.12.037","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium (Ophthalmology. 2018;125:1793-1802)","volume":"126","author":"Greenlee","year":"2019","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.005_bib0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ophtha.2019.10.013","article-title":"A novel multimethod image analysis to quantify pentosan polysulfate sodium retinal toxicity","volume":"127","author":"Hadad","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2019.3392","article-title":"Phenotypic spectrum of pentosan polysulfate sodium-associated maculopathy: a multicenter study","author":"Hanif","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.005_bib0017","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ophtha.2019.04.024","article-title":"Strength of association between pentosan polysulfate and a novel maculopathy","volume":"126","author":"Hanif","year":"2019","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.005_bib0018","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/IIO.0000000000000262","article-title":"Pattern dystrophy: an imprecise diagnosis in the age of precision medicine","volume":"59","author":"Hanif","year":"2019","journal-title":"Int Ophthalmol Clin"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.005_bib0019","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment","volume":"193","author":"Hanno","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0020","doi-asserted-by":"crossref","unstructured":"Higgins K, Welch RJ, Bacorn C, et\u00a0al. Identification of patients with pentosan polysulfate sodium-associated maculopathy through screening of the electronic medical record at an academic center. J Ophthalmol, December 17, 2020. doi:10.1155\/2020\/8866961.","DOI":"10.1155\/2020\/8866961"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.005_bib0021","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0022-5347(17)43241-1","article-title":"A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease","volume":"138","author":"Holm-Bentzen","year":"1987","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.005_bib0022","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3928\/23258160-20191009-10","article-title":"Progressive maculopathy after discontinuation of pentosan polysulfate sodium","volume":"50","author":"Huckfeldt","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.005_bib0023","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0090-4295(97)00110-6","article-title":"Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis","volume":"50","author":"Hwang","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0024","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.exer.2015.02.017","article-title":"Structure and function of the interphotoreceptor matrix surrounding retinal photoreceptor cells","volume":"133","author":"Ishikawa","year":"2015","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0025","article-title":"Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort","author":"Jain","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.005_bib0026","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ng1193-308","article-title":"A gene for Stargardt's disease (fundus flavimaculatus) maps to the short arm of chromosome 1","volume":"5","author":"Kaplan","year":"1993","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.005_bib0027","first-page":"1770","article-title":"Inhibition of growth factor effects in retinal pigment epithelial cells","volume":"32","author":"Leschey","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0028","article-title":"Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States","author":"Ludwig","year":"2019","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.005_bib0029","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/opo.12283","article-title":"Infrared reflectance imaging in age-related macular degeneration","volume":"36","author":"Ly","year":"2016","journal-title":"Ophthalmic Physiol Opt"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.005_bib0030","first-page":"1068","article-title":"Pentosan polysulfate maculopathy: comprehensive functional analysis and structure-function correlation","volume":"61","author":"Lyons","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.005_bib0031","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jamaophthalmol.2019.4992","article-title":"Retinal pigment abnormalities in a woman with diabetes","volume":"138","author":"Lyons","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.005_bib0032","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bju.14399","article-title":"Guideline of guidelines: bladder pain syndrome","volume":"122","author":"Malde","year":"2018","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.005_bib0033","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.oret.2019.08.006","article-title":"Choroidal neovascularization associated with pentosan polysulfate toxicity","volume":"4","author":"Mishra","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.005_bib0034","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0090-4295(90)80116-5","article-title":"Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study","volume":"35","author":"Mulholland","year":"1990","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.005_bib0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1464-5491.2008.02359.x","article-title":"Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation","volume":"25","author":"Murphy","year":"2008","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.005_bib0036","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.urology.2004.10.071","article-title":"Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis","volume":"65","author":"Nickel","year":"2005","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.005_bib0037","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.juro.2014.09.036","article-title":"Pentosan polysulfate sodium for treatment of interstitial cystitis\/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study","volume":"193","author":"Nickel","year":"2015","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.005_bib0038","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.juro.2018.02.011","article-title":"Criteria for interstitial cystitis\/bladder pain syndrome clinical trials: future direction for research","volume":"200","author":"Nickel","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0039","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2020.2778","article-title":"Fibroblast growth factor receptor inhibitor\u2013associated retinopathy","author":"Parikh","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.005_bib0040","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-5347(17)35629-X","article-title":"A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate","volume":"150","author":"Parsons","year":"1993","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.005_bib0041","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-5347(17)50948-9","article-title":"Successful treatment of interstitial cystitis with sodium pentosanpolysulfate","volume":"130","author":"Parsons","year":"1983","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.005_bib0042","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00404-017-4364-2","article-title":"Etiology, pathophysiology and biomarkers of interstitial cystitis\/painful bladder syndrome","volume":"295","author":"Patnaik","year":"2017","journal-title":"Arch Gynecol Obstet"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.005_bib0043","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0044","unstructured":"Practice Advisory: Possible drug induced retinal maculopathy secondary to long-term use of pentosan polysulfate sodium (Elmiron). American Urogynecologic Society. Published August 2020. Accessed February 26, 2021. https:\/\/www.augs.org\/publications\/practice-advisories\/"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.005_bib0045","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/01.ju.0000083020.06212.3d","article-title":"A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis","volume":"170","author":"Sant","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0046","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2020.2349","article-title":"Disease course in patients with pentosan polysulfate sodium-associated maculopathy after drug cessation","author":"Shah","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0047","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000003078","article-title":"Pentosan polysulfate and vision: findings from an international survey of exposed individuals","author":"Uner","year":"2021","journal-title":"RETINA"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0048","unstructured":"United States Food & Drug Administration. Drug Safety-related Labeling Changes (SrLC). U.S. Food & Drug Administration. Accessed July 21, 2020. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/safetylabelingchanges\/index.cfm?event=searchdetail.page&DrugNameID=2277"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2020.01.017","article-title":"Prevalence of maculopathy associated with long-term pentosan polysulfate therapy","author":"Vora","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0050","article-title":"A case of pentosan polysulfate maculopathy originally diagnosed as stargardt disease","volume":"17","author":"Vora","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.survophthal.2021.05.005_bib0051","article-title":"Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis","author":"Wang","year":"2020","journal-title":"Can J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.005_bib0052","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.ophtha.2020.07.048","article-title":"Large subfoveal vitelliform lesions in a case of pentosan polysulfate maculopathy","volume":"127","author":"Wannamaker","year":"2020","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.005_bib0053","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","article-title":"Pachychoroid pigment epitheliopathy","volume":"33","author":"Warrow","year":"2013","journal-title":"Retina Phila Pa"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625721001235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625721001235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:55:11Z","timestamp":1758542111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625721001235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0039625721001235"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2021.05.005","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentosan polysulfate maculopathy","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2021.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}